Human CD22 ELISA Kit0 Publications

Catalog number: KE00131

Be the first to review this product


Freight/Packing £00.00

Size: 09µ/gram

Please visit your regions distributor:

Images See all


Product name:
Human CD22 ELISA Kit

1 X 96 well plate

Sample type:
Serum, Plasma, Cell culture supernatants, Cell lysates

Assay type:

4.6 pg/mL

125-8000 pg/mL

Reacted Species:

Tested applications:
Sandwich ELISA

Sample TypeAverageRange
Human serum 97% 72%-125%
Cell culture supernatants 87% 75%-103%
Cell lysates 90% 71%-112%

Samplenmean ( pg/mL)SDCV%
1 20 3,996.4 339.2 8.5
2 20 991.2 78.3 7.9
3 20 224.0 12.3 5.5

Samplenmean ( pg/mL)SDCV%
1 24 3,493.8 362.8 10.4
2 24 993.0 95.4 9.6
3 24 244.4 25.2 10.3

Product overview:
KE00131 is a solid phase sandwich Enzyme Linked-Immuno-Sorbent Assay (Sandwich ELISA). The CD22 ELISA kit is to be used to detect and quantify protein levels of endogenous CD22. The assay recognizes human CD22. An antibody specific for CD22 has been pre-coated onto the microwells. The CD22 protein in samples is captured by the coated antibody after incubation. Following extensive washing, another antibody of biotinylated specific for human CD22 is added to detect the captured human CD22 protein. For signal development, Streptavidin-HRP is added, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450nm with the correction wavelength set at 630 nm.


Storage Instructions:
All the reagents are stored at 2-8℃. Refer to the protocol for further storage instructions.

B cell receptor CD22, BL CAM, CD22, CD22 molecule, FLJ22814, SIGLEC 2, SIGLEC2, T cell surface antigen Leu 14

CD22, also known as Siglec-2 (sialic acid binding Ig-like lectin 2) or BL-CAM (B-lymphocyte cell adhesion molecule), is a 130-140 kDa, B-cell restricted, type I transmembrane glycoprotein belonging to the immunoglobulin gene superfamily. The expression of CD22 is developmentally regulated. It is expressed at low levels in the cytoplasm of pro-B and pre-B cells and present on the cell surface only at mature stages of B-cell differentiation. Cell surface expression is lost during terminal differentiation into plasma cell and after B-cell activation. CD22 is an inhibitory receptor for B-cell receptor (BCR) signalling, preferentially binds to alpha-2,6-linked sialic acid and mediates B-cell B-cell interactions. It plays a crucial role in activation and differentiation of the B-cell. Soluble form of CD22 (sCD22) has been found in human serum and may be useful as a tumor marker for hairy cell leukemia.

to top